top of page

Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Dacoplice 30mg Tablet

Dacoplice 30mg Tablet

Manufacturer/Marketed By : PFIZER LTD

$639.41 $511.53

Dacoplice 30mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. This medicine is mainly prescribed as a first-line...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

DACOMITINIB

Active Pharmaceutical Ingredient

Dacoplice 30mg Tablet

SKU PFIZER LTD
Prix d’origine

639,41$

Prix promotionnel

511,53$

Dacoplice 30mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. This medicine is mainly prescribed as a first-line treatment for non-small cell lung cancer (NSCLC) that has spread to other parts of the body, especially in cases where tests show specific mutations in the EGFR (epidermal growth factor receptor) gene. Patients often search for information such as Dacoplice 30mg price, availability of Dacoplice 30mg online, and suitable Dacoplice 30mg substitutes before starting treatment. The recommended Dacoplice 30mg dosage should only be determined by the treating oncologist based on the patient’s health condition and cancer progression. Since it is primarily prescribed as Dacoplice 30mg for lung cancer, understanding the Dacoplice 30mg composition is important for patients and caregivers. The drug is manufactured under strict pharmaceutical standards, and details of the Dacoplice 30mg manufacturer can be verified on the packaging. For patients who may face financial challenges, there are often support options such as a Dacoplice 30mg patient assistance program, which can help in accessing this medication at a reduced cost.

Active Pharmaceutical Ingredient

DACOMITINIB

Uses

• Metastatic non-small cell lung cancer with positive EGFR

Benefits

Dacoplice 30mg Tablet is used in the treatment of certain types of blood cancers by helping to control the growth and spread of abnormal cells. It works by interfering with processes involved in cell development, leading to the destruction of cancer cells or slowing their multiplication. This helps manage disease progression and improves response to treatment. It may also help relieve symptoms associated with the condition, supporting better overall health. Regular use as prescribed contributes to effective disease control and enhances quality of life.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Dacoplice 30mg side effects are

Most Common Side Effects

• Severe itchy skin
• Diarrhea
• Respiratory illness

Common Side Effects

• Hair fall
• Inflammation in the nails
• Itchy skin
• Dry skin
• Decreased weight
• Decreased appetite
• Inflamed and sore mouth
• cough

How To Use

Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Take this medicine with a meal to avoid stomach problems. Take the tablet at about the same time each day.

Safety Advice

• Breast Feeding: Breastfeeding is not recommended in patients taking Dacoplice 30mg Tablet because the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: It is not known whether it is safe to consume alcohol with Dacoplice 30mg Tablet. Please consult your doctor.
• Liver: Dacoplice 30mg Tablet is safe when administered in patients with liver diseases. No dose adjustments are necessary for mild, moderate or severe liver failure. Inform your physician if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether Dacoplice 30mg Tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Driving or operating heavy machinery is unsafe after taking Dacoplice 30mg Tablet because you may feel dizzy, drowsy, or have eye irritation.
• Pregnancy: Dacoplice 30mg Tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. An effective birth control method is necessary during the treatment and for 17 days after your last dose.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page